A single dose 4-part crossover study to determine the comparative bioavailability of an oral liquid formulation of paroxetine (20 mg pfb) and a standard 20 mg pfb Paxil tablet administered immediately...

Mise à jour : Il y a 5 ans
Référence : GSK29060/440

A single dose 4-part crossover study to determine the comparative bioavailability of an oral liquid formulation of paroxetine (20 mg pfb) and a standard 20 mg pfb Paxil tablet administered immediately before and after breakfast

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait


Liens